Alzheimer’s disease market to reach $17 billion in 8MM by 2033, forecasts GlobalData

Sarepta to seek approval for gene therapy in rare muscular dystrophy

DRRA9 minutes ago 0

FDA ‘green list’ flagging illegal GLP-1RA compounders is long overdue

DRRA1 hour ago 0

Canadian lawmakers call on government to halt imports of long-tailed macaques

DRRA1 hour ago 0

LogiPharma USA 2025: The Value of Visibility, Technology, and Trust

DRRA2 hours ago 0